21561-22-8 Usage
Uses
Used in Agricultural Industry:
1-(2-chloroethyl)-3-(2,6-dimethoxyphenyl)urea is used as a herbicidal agent for controlling the growth of broadleaf weeds in various crops and non-crop areas. Its application reason is its ability to inhibit a key enzyme involved in amino acid synthesis, leading to the death of the targeted plants and providing effective weed control.
Used in Non-Crop Areas:
1-(2-chloroethyl)-3-(2,6-dimethoxyphenyl)urea is also used as a herbicide in non-crop areas to manage the growth of unwanted broadleaf weeds. Its application reason is the same as in the agricultural industry, where it targets the enzyme responsible for amino acid synthesis in plants, thus providing an effective solution for weed management in non-agricultural settings.
Check Digit Verification of cas no
The CAS Registry Mumber 21561-22-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,1,5,6 and 1 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 21561-22:
(7*2)+(6*1)+(5*5)+(4*6)+(3*1)+(2*2)+(1*2)=78
78 % 10 = 8
So 21561-22-8 is a valid CAS Registry Number.
21561-22-8Relevant academic research and scientific papers
New substituted 1-(2,3-dihydrobenzo[1,4]dioxin-2-ylmethyl)piperidin-4-yl derivatives with α2-adrenoceptor antagonist activity
Mayer,Brunel,Chaplain,Piedecoq,Calmel,Schambel,Chopin,Wurch,Pauwels,Marien,Vidaluc,Imbert
, p. 3653 - 3664 (2007/10/03)
The emergence of a novel theory concerning the role of noradrenaline in the progression and the treatment of neurodegenerative diseases such as Parkinson's and Alzheimer's diseases has provided a new impetus toward the discovery of novel compounds acting at α2-adrenoceptors. A series of substituted 1-(2,3-dihydrobenzo[1,4]dioxin-2-ylmethyl)piperidin-4-yl derivatives bearing an amide, urea, or imidazolidinone moiety was studied. Some members of this series of compounds proved to be potent α2-adrenoceptor antagonists with good selectivity versus α1-adrenergic and D2-dopamine receptors. Particular emphasis is given to compound 33g which displays potent α2-adrenoceptor binding affinity in vitro and central effects in vivo following oral administration.
